Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression

J Clin Pharmacol. 1995 Sep;35(9):876-84. doi: 10.1002/j.1552-4604.1995.tb04132.x.


A study of a dopaminergic antidepressant that may have an advantageous profile for use in elderly patients, bupropion, was conducted to determine the pharmacokinetics of bupropion in the elderly. Pharmacokinetics of single- and multiple-dose bupropion were examined in six elderly patients (five women and one man) diagnosed with depression. Mean (+/- SD) CL app of bupropion was 1.6 +/- 0.4 L/hr/kg, approximately 80% of the corresponding value reported for younger patients. Mean bupropion t1/2 was 34.2 +/- 8.7 hours, and average apparent Vd (Vd app) was 79.3 +/- 29.4 L/kg. Apparent half-lives (t1/2 app) of the metabolites hydroxybupropion, erythrobupropion, and threohydrobupropion were 34.2 +/- 4.6 hours, 61.4 +/- 21.6 hours, and 38.8 +/- 7.6 hours, respectively. After multiple dosing, the mean t1/2 for bupropion and its metabolites did not change significantly, although in some patients the t1/2 app of the metabolites was substantially prolonged. There was also evidence of inordinate accumulation of metabolites. The elderly are at risk for accumulation of bupropion and its metabolites. Specification of therapeutic drug monitoring parameters for bupropion treatment of the elderly is needed.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Aged
  • Antidepressive Agents, Second-Generation / pharmacokinetics*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Bupropion / pharmacokinetics*
  • Bupropion / therapeutic use
  • Depression / drug therapy
  • Depression / metabolism*
  • Dopamine Uptake Inhibitors / pharmacokinetics*
  • Dopamine Uptake Inhibitors / therapeutic use
  • Drug Administration Schedule
  • Female
  • Half-Life
  • Humans
  • Male
  • Middle Aged


  • Antidepressive Agents, Second-Generation
  • Dopamine Uptake Inhibitors
  • Bupropion